60d FRN - published

6546

Federal Register / Vol. 85, No. 24 / Wednesday, February 5, 2020 / Notices

Comments received generally will be
posted without change to http://
www.regulations.gov, including any
personal and/or business confidential
information provided. To confirm
receipt of your comment(s), please
check www.regulations.gov,
approximately two to three days after
submission to verify posting (except
allow 30 days for posting of comments
submitted by mail).
FOR FURTHER INFORMATION CONTACT:
Zenaida Delgado, Procurement Analyst,
at telephone 202–969–7207, or
zenaida.delgado@gsa.gov.
SUPPLEMENTARY INFORMATION:

9000–0012, Termination Settlement
Proposal Forms—FAR (SF 1435 through
1440).
B. Needs and Uses
The termination settlement proposal
forms (Standard Forms 1435 through
1440) provide a standardized format for
listing essential cost and inventory
information needed to support the
terminated contractor’s negotiation
position per the Federal Acquisition
Regulation subpart 49.6, Contract
Termination Forms and Formats.
Submission of the information assures
that a contractor will be fairly
reimbursed upon settlement of the
terminated contract.
C. Annual Burden
Respondents: 4,995.
Total Annual Responses: 14,128.
Total Burden Hours: 33,907.
D. Public Comment

jbell on DSKJLSW7X2PROD with NOTICES

A 60-day notice was published in the
Federal Register at 84 FR 65158, on
November 26, 2019. No comments were
received.
Obtaining Copies: Requesters may
obtain a copy of the information
collection documents from the General
Services Administration, Regulatory
Secretariat Division (MVCB), 1800 F
Street NW, Washington, DC 20405,
telephone 202–501–4755. Please cite
OMB Control No. 9000–0012,
Termination Settlement Proposal
Forms—FAR (SF 1435 through 1440), in
all correspondence.
Dated: January 30, 2020.
Janet Fry,
Director, Federal Acquisition Policy Division,
Office of Governmentwide Acquisition Policy,
Office of Acquisition Policy, Office of
Governmentwide Policy.
BILLING CODE 6820–EP–P

VerDate Sep<11>2014

18:54 Feb 04, 2020

Jkt 250001

Centers for Disease Control and
Prevention
[60Day–20–20HF; Docket No. CDC–2020–
0012]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS)
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ‘‘2019 Novel Coronavirus Airport
Entry Questionnaires and Aircraft
Contact Investigations Information
Collection,’’ which will provide CDC
with the ability to perform enhanced
public health assessments of travelers
from China, or other areas affected by
the 2019 Novel Coronavirus (2019–
nCoV) outbreak, to determine risk of
infection with 2019-nCoV, and to
facilitate any necessary public health
follow-up.
DATES: CDC must receive written
comments on or before April 6, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0012 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov. Please note: Submit all
comments through the Federal
eRulemaking portal (regulations.gov) or
by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger, of
the Information Collection Review
SUMMARY:

A. OMB Control Number, Title, and
Any Associated Form(s)

[FR Doc. 2020–02205 Filed 2–4–20; 8:45 am]

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

PO 00000

Frm 00050

Fmt 4703

Sfmt 4703

Office, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
2019 Novel Coronavirus Airport Entry
Questionnaires and Contact
Investigations—New Emergency—
National Center for Emerging Zoonotic
and Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC and the Department of Homeland
Security (DHS) have been tasked with
conducting risk assessment activities at
international U.S. airports to detect
individuals ill or at risk of being ill with
2019–nCoV. This primarily involves
travelers coming from China. As the
outbreak evolves, travelers from

E:\FR\FM\05FEN1.SGM

05FEN1

6547

Federal Register / Vol. 85, No. 24 / Wednesday, February 5, 2020 / Notices
additional countries may be assessed for
risk of 2019–nCoV infection at U.S.
airports.
The information collected will be
limited to that necessary to confirm the
individual’s identity, establish their
travel itinerary, and make a public
health risk assessment. This includes
travel itinerary data, information about
who the traveler is, and contact and
locating information sufficient to
complete potential follow-up after
arrival. CDC will also observe travelers
to determine if the traveler is
experiencing any overt signs and
symptoms of disease, as well as ask
basic questions about signs or symptoms
of illness. The information also includes
a field for a temperature, which will be
taken via a non-contact thermometer.
CDC will require all travelers from
Wuhan, China, and any symptomatic
travelers from China, to provide
information as part of an initial public
health risk assessment. Travelers from

associated with the disease for a period
of up to two weeks (14 days) after
arrival, depending on exposure risks
and whether or not they develop
symptoms.
CDC is also seeking authorization to
ask state and local health departments
to administer questionnaires to air
travelers who may have been exposed to
a case of 2019-nCoV. In the event a
confirmed case of 2019-nCoV flew to the
United States, CDC will distribute the
questionnaires to state health
departments and ask them to make
contact with their respective residents
to determine if additional public health
follow-up is needed. CDC will then ask
the state health department to return the
completed questionnaires. In limited
circumstances, CDC may make direct
contact with the at-risk travelers. There
are no costs to respondents other than
their time. The total estimated burden
hours requested are 36,751.

other areas may be required to answer
questions as part of a risk assessment if
there is a demonstrated risk of
exportation to the United States.
If an individual from an area where
the virus is spreading has a fever,
answers ‘‘Yes’’ to any of the symptom
questions, or has visible signs of specific
symptoms, they will be required to
undergo a further public health
evaluation that will ask more in-depth
health and exposure-related questions.
In the event that there is a repatriation
of U.S. citizens or other groups from
foreign countries to the United States,
and those individuals are coming from
areas experiencing an outbreak of 2019nCoV, individuals may be required to
respond to a pre-boarding health
screening and a questionnaire to assess
their risk of infection depending on the
risk of exposure. CDC may monitor
individuals repatriated to the United
States from areas experiencing an
outbreak of 2019-nCoV for symptoms

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in minutes)

Total burden
hours

Form

Traveler ..........................

100,000

1

10/60

16,667

5,000

1

15/60

1,250

..........................
..........................
..........................
..........................
..........................

United States Travel Health Declaration (English
or Mandarin Chinese).
United States Travel Health Declaration for Repatriation.
2019n-CoV Supplemental Questionnaire ............
Preboarding Health Screen .................................
2019-nCoV Air CI Basic Questionnaire ...............
2019-nCoV Air CI Follow-up Questionnaire ........
2019-nCoV Daily Symptom Check ......................

5,000
5,000
5,500
5,500
5,000

1
1
1
1
28

15/60
5/60
30/60
30/60
5/60

1,250
417
2,750
2,750
11,667

Total ........................

..............................................................................

........................

........................

........................

36,751

Traveler ..........................
Traveler
Traveler
Traveler
Traveler
Traveler

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–02266 Filed 2–4–20; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2018–N–4337]

jbell on DSKJLSW7X2PROD with NOTICES

Number of
responses per
respondent

Number of
respondents

Respondent

Prescription Drug User Fee Act of
2017; Electronic Submissions and Data
Standards; Public Meeting; Request
for Comments
AGENCY:

Food and Drug Administration,

The public meeting will be held
on April 22, 2020, from 9 a.m. to 4 p.m.
Submit either electronic or written
comments on this public meeting by

DATES:

HHS.
Notice of public meeting;
request for comments.

ACTION:

VerDate Sep<11>2014

The Food and Drug
Administration (FDA or Agency) is
announcing the following public
meeting entitled ‘‘Prescription Drug
User Fee Act of 2017; Electronic
Submissions and Data Standards.’’ The
purpose of the public meeting and the
request for comments is to fulfill FDA’s
commitment to seek stakeholder input
related to data standards and the
electronic submission system’s past
performance, future targets, emerging
industry needs, and technology
initiatives. FDA will use the information
from the public meeting as well as from
comments submitted to the docket to
inform data standards initiatives, FDA
Information Technology (IT) Strategic
Plan, and electronic submissions
gateway target timeframes.

SUMMARY:

18:54 Feb 04, 2020

Jkt 250001

PO 00000

Frm 00051

Fmt 4703

Sfmt 4703

April 22, 2020. See the SUPPLEMENTARY
section for registration date
and information.
ADDRESSES: The public meeting will be
held at the FDA White Oak Campus,
10903 New Hampshire Ave., Building
31 Conference Center, the Great Room
(Rm. 1503, Section A), Silver Spring,
MD 20993–0002. Entrance for public
meeting participants (non-FDA
employees) is through Building 1, where
routine security check procedures will
be performed. For parking and securing
information, please refer to https://
www.fda.gov/AboutFDA/
WorkingatFDA/BuildingsandFacilities/
WhiteOakCampusInformation/
ucm241740.htm.
You may submit comments as
follows. Please note that late, untimely
filed comments will not be considered.
Electronic comments must be submitted
on or before April 22, 2020. The https://
www.regulations.gov electronic filing
INFORMATION

E:\FR\FM\05FEN1.SGM

05FEN1